Astellas delves deeper into protein degrading drugs with Cullgen deal

Astellas Pharma has partnered with biotechnology startup Cullgen to develop drugs that break down, rather than block, disease-causing proteins, becoming the latest large pharmaceutical company to team with a biotech working in the emerging field.